GR3021117T3 - Promotion of wound-healing with 15-keto-prostaglandin compounds - Google Patents

Promotion of wound-healing with 15-keto-prostaglandin compounds

Info

Publication number
GR3021117T3
GR3021117T3 GR960402483T GR960402483T GR3021117T3 GR 3021117 T3 GR3021117 T3 GR 3021117T3 GR 960402483 T GR960402483 T GR 960402483T GR 960402483 T GR960402483 T GR 960402483T GR 3021117 T3 GR3021117 T3 GR 3021117T3
Authority
GR
Greece
Prior art keywords
keto
wound
healing
promotion
prostaglandin compounds
Prior art date
Application number
GR960402483T
Other languages
English (en)
Inventor
Ryuji Ueno
Original Assignee
R Tech Ueno Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=13554827&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=GR3021117(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by R Tech Ueno Ltd filed Critical R Tech Ueno Ltd
Publication of GR3021117T3 publication Critical patent/GR3021117T3/el

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Ophthalmology & Optometry (AREA)
  • Dermatology (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
GR960402483T 1991-03-14 1996-09-20 Promotion of wound-healing with 15-keto-prostaglandin compounds GR3021117T3 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP7470291 1991-03-14

Publications (1)

Publication Number Publication Date
GR3021117T3 true GR3021117T3 (en) 1996-12-31

Family

ID=13554827

Family Applications (1)

Application Number Title Priority Date Filing Date
GR960402483T GR3021117T3 (en) 1991-03-14 1996-09-20 Promotion of wound-healing with 15-keto-prostaglandin compounds

Country Status (12)

Country Link
US (1) US5252605A (el)
EP (1) EP0503887B1 (el)
JP (1) JP2515458B2 (el)
KR (1) KR100221370B1 (el)
AT (1) ATE141794T1 (el)
AU (1) AU648877B2 (el)
CA (1) CA2062653C (el)
DE (1) DE69213057T2 (el)
DK (1) DK0503887T3 (el)
ES (1) ES2093774T3 (el)
GR (1) GR3021117T3 (el)
NZ (1) NZ241940A (el)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3209427B2 (ja) * 1992-02-07 2001-09-17 科研製薬株式会社 創傷または痔疾治療剤
TW420611B (en) * 1995-03-10 2001-02-01 R Tech Ueno Ltd Pharmaceutical composition containing prostanoic acid compounds for the treatment of optic nerve disorder
DK0857718T3 (da) 1996-06-10 2002-12-16 Sucampo Ag Endothelinantagonist
PT978284E (pt) * 1997-11-28 2008-10-07 Sucampo Ag Utilização de compostos 15-ceto-prostaglandina-e como antagonistas da endotelina
TWI225398B (en) 1999-07-14 2004-12-21 R Tech Ueno Ltd Composition for treatment of external secretion disorders
NZ529406A (en) * 2001-05-18 2005-09-30 Sucampo Ag Halogenated prostaglandin derivatives for treating constipation and cleansing the gastrointestinal tract
TWI331920B (en) * 2001-11-14 2010-10-21 Sucampo Ag Unit dosage form for relieving or treating constipation in human patients
US20050124699A1 (en) * 2002-07-02 2005-06-09 Wakamoto Pharmaceutical Co., Ltd. Drugs for treating or preventing disorders of corneal and/or conjunctival epithelial cells
CN1665514A (zh) * 2002-07-02 2005-09-07 若素制药株式会社 治疗或预防角结膜上皮细胞损伤的药物
MXPA05010552A (es) 2003-04-02 2005-11-23 Nexmed Holdings Inc Composiciones de prostaglandina y su uso para el tratamiento de vasoespasmos.
JP5213448B2 (ja) * 2005-03-04 2013-06-19 スキャンポ・アーゲー 末梢血管疾患の処置のための方法および組成物
EP1984027B1 (en) 2006-01-24 2015-12-30 R-Tech Ueno, Ltd. Pharmaceutical composition comprising a bi-cyclic compound and method for stabilizing the bi-cyclic compound
US20090082442A1 (en) * 2007-09-26 2009-03-26 Protia, Llc Deuterium-enriched lubiprostone
US8871752B2 (en) * 2008-02-19 2014-10-28 Sucampo Ag Method for modulating stem cell growth
CA2639240A1 (en) * 2008-08-29 2010-02-28 Alphora Research Inc. Prostaglandin synthesis and intermediates for use therein
US8513441B2 (en) 2008-08-29 2013-08-20 Alphora Research Inc. Prostaglandin synthesis and intermediates for use therein
WO2010083597A1 (en) * 2009-01-22 2010-07-29 Apotex Pharmachem Inc. Methods of making lubiprostone and intermediates thereof
US8609729B2 (en) * 2009-04-15 2013-12-17 Sucampo Ag Method for treating macular degeneration
WO2012139033A1 (en) 2011-04-07 2012-10-11 Nexmed Holdings, Inc. Methods and compositions for treating raynaud's disease
JP6957610B2 (ja) 2016-10-06 2021-11-02 スキャンポ・アーゲーＳｕｃａｍｐｏ ＡＧ 医薬品用途のための多層ビーズ

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2740953A1 (de) * 1977-09-12 1979-03-22 Thera Ges Fuer Patente Verwendung von prostaglandinen zur senkung des blutzuckerspiegels
EP0153858A3 (en) * 1984-02-29 1985-12-11 The Upjohn Company The therapeutic use of prostaglandins
JPS60208917A (ja) * 1984-02-29 1985-10-21 ジ・アツプジヨン・カンパニー Ａｒｄｓおよび多器官不全治療、予防におけるプロスタグランジンの使用
CA1322749C (en) * 1987-01-28 1993-10-05 Ryuzo Ueno Prostaglandins of the d series, and tranquilizers and soporifics containing the same
US5166174A (en) * 1987-01-28 1992-11-24 K.K. Ueno Seiyaku Oyo Kenkyujo Prostaglandins E and anti-ulcers containing same
CA1323364C (en) * 1987-01-28 1993-10-19 Ryuzo Ueno Prostaglandins e and anti ulcer agents containing same
CA1324129C (en) * 1987-04-30 1993-11-09 Ryuzo Ueno Prostaglandins of the f series
ES2038289T3 (es) * 1987-05-15 1993-07-16 Kabushiki Kaisha Ueno Seiyaku Oyo Kenkyujo Utilizacion de 15-ceto-pges para la fabricacion de un medicamento para aumentar la temperatura corporal.
ATE82499T1 (de) * 1987-09-18 1992-12-15 R Tech Ueno Ltd Okulare hypotensivagenzien.
DE3873007T2 (de) * 1987-10-02 1992-12-03 Ueno Seiyaku Oyo Kenkyujo Kk Kathartica.
JP2597629B2 (ja) * 1988-02-26 1997-04-09 株式会社 上野製薬応用研究所 １３，１４−ジヒドロ−１５−ケトプロスタグランジン類の安定化
AU619543B2 (en) * 1988-05-11 1992-01-30 Sucampo Ag Use of 15-ketoprostaglandin e or f compounds for uterine contraction
JP2597649B2 (ja) * 1988-05-11 1997-04-09 株式会社上野製薬応用研究所 気管・気管支拡張剤
EP0343904B1 (en) * 1988-05-23 1993-04-28 Kabushiki Kaisha Ueno Seiyaku Oyo Kenkyujo Hypersphyxia causing composition
JP2579193B2 (ja) * 1988-07-19 1997-02-05 小野薬品工業株式会社 １６，１６−ジフルオロ−１５−オキソ−１５−デオキシｐｇｅ誘導体

Also Published As

Publication number Publication date
JP2515458B2 (ja) 1996-07-10
AU1286192A (en) 1992-09-17
KR920017655A (ko) 1992-10-21
EP0503887A3 (en) 1993-01-13
ES2093774T3 (es) 1997-01-01
CA2062653A1 (en) 1992-09-15
EP0503887B1 (en) 1996-08-28
DK0503887T3 (da) 1996-09-16
DE69213057T2 (de) 1997-01-09
US5252605A (en) 1993-10-12
JPH0570354A (ja) 1993-03-23
CA2062653C (en) 2002-08-20
KR100221370B1 (ko) 1999-09-15
AU648877B2 (en) 1994-05-05
DE69213057D1 (de) 1996-10-02
ATE141794T1 (de) 1996-09-15
NZ241940A (en) 1997-07-27
EP0503887A2 (en) 1992-09-16

Similar Documents

Publication Publication Date Title
EP0503887A3 (en) Promotion of wound-healing with 15-keto-prostaglandin compounds
GR3027666T3 (en) Treatment of cataract with 15-keto-prostaglandin compounds
EP0435443A3 (en) Use of 15-keto-prostaglandin compound for improvement of encephalic function
AU549481B2 (en) Hair growing agent
EP0455448A3 (en) Treatment of pancreatic disease with 15-keto-prostaglandin compounds
GR3019760T3 (en) Treatment of inflammatory diseases with 15-keto-prostaglandin compounds
GR3018674T3 (en) Treatment of hepatobiliary disease with 15-keto-prostaglandin compounds
GR3026105T3 (en) Treatment of cardiac dysfunction with 15-keto-prostaglandin compounds
EP0430552A3 (en) Treatment of pulmonary dysfunction with 15-keto-prostaglandin compounds
GR3001277T3 (en) Chlorpheniramine therapy
GR3022217T3 (en) Treatment of cataract with prostacyclin compounds
AU7593091A (en) Biochemical treatment with 15-dehydroxy-16-oxoprostaglandin compounds
SE8802040D0 (sv) New use
GR920300126T1 (el)